PREPOPIK (Ferring Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the PREPOPIK drug offered from Ferring Pharmaceuticals Inc.. This Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ferring Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID |
| SUBSTANCE NAME: | SODIUM PICOSULFATE; MAGNESIUM OXIDE; ANHYDROUS CITRIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-07-16 |
| END MARKETING DATE: | 0000-00-00 |
PREPOPIK HUMAN PRESCRIPTION DRUG Details:
| Item Description | PREPOPIK from Ferring Pharmaceuticals Inc. |
| LABELER NAME: | Ferring Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 3.5; 12(mg/16.1g; g/16.1g; g/16.1g) |
| START MARKETING DATE: | 2012-07-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55566-9300_595f8f67-d01f-4d75-831c-7a6a49cf4238 |
| PRODUCT NDC: | 55566-9300 |
| APPLICATION NUMBER: | NDA202535 |
Other SODIUM PICOSULFATE; MAGNESIUM OXIDE; ANHYDROUS CITRIC ACID Pharmaceutical Manufacturers / Labelers:
